Skip to main content
. 2014 Sep 20;4:8. doi: 10.1186/s13588-014-0008-8

Table 2.

Percentage growth inhibition by sesquiterpenes (1 to 7)

  Compound
Cell line 1 2 3 4 5 6/7
HT29a 60?±?3 12?±?2 12?±?5 >100 <10 10?±?5
U87b 25?±?2 13?±?6 15?±?7 52?±?2 12?±?4 15?±?6
MCF-7c 81?±?6 <10 <10 >100 <10 <10
A2780d 65?±?5 <10 <10 99?±?1 <10 <10
H460e 11?±?1 <10 <10 71?±?1 <10 <10
A431f 86?±?1 <10 <10 >100 <10 <10
Du145g 41?±?1 23?±?6 18?±?3 92?±?2 18?±?2 17?±?3
BE2-Ch >100 <10 <10 >100 <10 <10
SJ-G2b 40?±?5 <10 10?±?3 >100 12?±?3 14?±?3
MIAi 47?±?2 12?±?4 17?±?3 92?±?2 18?±?3 19?±?2
SMAj 34?±?8 <10 <10 95?±?1 <10 <10
MCF10Ak 10?±?6 <10 <10 31?±?10 <10 <10

Isoaplysin (1), isolaurenisol (2), debromoisolaurinterol (3), debromoaplysinol (4), laur-11-en-10-ol (5), and a 1:1 mixture of the 3?-hydroxydebromoaplysin (6) and 10-bromo-1,7-dien-3-ol (7) against a panel of cancer and non-cancer derived cell lines at a single dose (25 ?M). Values are measured relative to an untreated control. aColon; bglioblastoma; cbreast; dovarian; elung; fskin; gprostate; hneuroblastoma; ipancreas; jglioblastoma (murine); kbreast (normal).